Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mycobacterium tuberculosis | Thymidylate kinase Tmk (dTMP kinase) (thymidylic acid kinase) (TMPK) | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Ceramide kinase | 0.0536 | 0 | 0.5 |
Schistosoma mansoni | sphingoid long chain base kinase | 1.3767 | 1 | 1 |
Trypanosoma cruzi | Diacylglycerol kinase catalytic domain containing protein, putative | 0.0536 | 0 | 0.5 |
Echinococcus multilocularis | sphingosine kinase 1 | 1.3767 | 1 | 1 |
Onchocerca volvulus | 0.0536 | 0 | 0.5 | |
Trypanosoma cruzi | Sphingosine kinase | 0.0536 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase-like protein, putative | 0.0536 | 0 | 0.5 |
Toxoplasma gondii | diacylglycerol kinase catalytic domain-containing protein | 0.0536 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, putative | 0.0536 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0536 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, zeta, iota, putative | 0.0536 | 0 | 0.5 |
Trypanosoma cruzi | Sphingosine kinase | 0.0536 | 0 | 0.5 |
Plasmodium falciparum | diacylglycerol kinase, putative | 0.0536 | 0 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0536 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0536 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase, putative | 0.0536 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, putative | 0.0536 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0536 | 0 | 0.5 |
Trypanosoma brucei | Diacylglycerol kinase catalytic domain containing protein, putative | 0.0536 | 0 | 0.5 |
Brugia malayi | diacylglycerol kinase | 0.0536 | 0 | 0.5 |
Leishmania major | diacylglycerol kinase-like protein | 0.0536 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, zeta, iota, putative | 0.0536 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0536 | 0 | 0.5 |
Brugia malayi | diacylglycerol kinase | 0.0536 | 0 | 0.5 |
Trichomonas vaginalis | bmru protein, putative | 0.0536 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 1.3767 | 1 | 1 |
Brugia malayi | Eye-specific diacylglycerol kinase | 0.0536 | 0 | 0.5 |
Leishmania major | sphingosine kinase A, B, putative | 0.0536 | 0 | 0.5 |
Brugia malayi | Diacylglycerol kinase protein 2 | 0.0536 | 0 | 0.5 |
Toxoplasma gondii | diacylglycerol kinase accessory domain (presumed) domain-containing protein | 0.0536 | 0 | 0.5 |
Leishmania major | diacylglycerol kinase, putative | 0.0536 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 1.3767 | 1 | 1 |
Trichomonas vaginalis | sphingosine kinase, putative | 0.0536 | 0 | 0.5 |
Trypanosoma brucei | Sphingosine kinase | 0.0536 | 0 | 0.5 |
Trypanosoma brucei | diacylglycerol kinase, putative | 0.0536 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase-like protein, putative | 0.0536 | 0 | 0.5 |
Trichomonas vaginalis | sphingosine kinase, putative | 0.0536 | 0 | 0.5 |
Plasmodium vivax | diacylglycerol kinase, putative | 0.0536 | 0 | 0.5 |
Schistosoma mansoni | sphingosine kinase A B | 1.3767 | 1 | 1 |
Plasmodium falciparum | diacylglycerol kinase, putative | 0.0536 | 0 | 0.5 |
Onchocerca volvulus | Ceramide kinase 1 homolog | 0.0536 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 1.3767 | 1 | 1 |
Trypanosoma cruzi | diacylglycerol kinase, putative | 0.0536 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, epsilon, putative | 0.0536 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0536 | 0 | 0.5 |
Plasmodium vivax | diacylglycerol kinase, putative | 0.0536 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 1.3767 | 1 | 1 |
Toxoplasma gondii | diacylglycerol kinase, putative | 0.0536 | 0 | 0.5 |
Trichomonas vaginalis | bmru protein, putative | 0.0536 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 0.93 uM | Inhibition of Mycobacterium tuberculosis Thymidine monophosphate kinase by spectrophotometry | ChEMBL. | 20951473 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.